0.9405USD+0.07%Mkt Cap: 42.10M USDP/E: —Last update: 2026-06-01
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's a…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap42.10M USD
Enterprise Value59.75M USD
Revenue (TTM)80.81M USD
Gross Profit54.34M USD
Net Income (TTM)-38.83M USD
Revenue/Share1.618 USD
Last Price0.9405 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees218
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.74
PEG—
EV/EBITDA-1.82
EV/Revenue0.74
P/S0.54
P/B6.83
EPS (TTM)-0.79
EPS (Forward)-0.56
52W Range
0.501026% of range2.200
52W High2.200 USD
52W Low0.5010 USD
Profitability
Gross Margin67.69%
Oper. Margin-55.23%
EBITDA Margin-40.60%
Profit Margin-48.37%
ROE-615.10%
ROA-47.69%
Growth
Revenue Growth2.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-28.22M USD
CapEx (TTM)448.00K USD
FCF Margin—
FCF Yield—
Net Debt16.32M USD
Net Debt/EBITDA-0.50
Balance Sheet
Debt/Equity8.90
Current Ratio3.61
Quick Ratio2.76
Book Value/Sh0.1420 USD
Cash/Share0.8830 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)2.250 USD
Target Range1.000 USD – 3.250 USD
# Analysts5
Ownership
Shares Out.44.77M
Float19.48M
Insiders7.47%
Institutions68.99%
Short Interest
Short Ratio3.2d
Short % Float2.55%
Short % Out.1.76%
Shares Short787.04K
Short (prev mo.)756.59K
Technical
SMA 500.7916 (+18.8%)
SMA 2001.112 (-15.4%)
Beta—
S&P 52W Chg27.70%
Avg Vol (30d)209.30K
Avg Vol (10d)113.76K
Technical Indicators
RSI (14)54.1
MACD0.0209
MACD Signal0.0347
MACD Hist.-0.0138
BB Upper1.132 USD
BB Middle0.9565 USD
BB Lower0.7805 USD
BB Width36.80%
ATR (14)0.1199 USD
Vol Ratio (20d)0.23x